Ilia Fishbein

3.0k total citations
61 papers, 2.4k citations indexed

About

Ilia Fishbein is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ilia Fishbein has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ilia Fishbein's work include Coronary Interventions and Diagnostics (16 papers), RNA Interference and Gene Delivery (12 papers) and Virus-based gene therapy research (11 papers). Ilia Fishbein is often cited by papers focused on Coronary Interventions and Diagnostics (16 papers), RNA Interference and Gene Delivery (12 papers) and Virus-based gene therapy research (11 papers). Ilia Fishbein collaborates with scholars based in United States, Israel and Germany. Ilia Fishbein's co-authors include Gershon Golomb, Michael Chorny, Robert J. Levy, Ivan S. Alferiev, Haim Danenberg, Shmuel Banai, Jianchuan Gao, Gary Friedman, Irith Gati and Stanisław Sosnowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Biomaterials.

In The Last Decade

Ilia Fishbein

59 papers receiving 2.3k citations

Peers

Countries citing papers authored by Ilia Fishbein

Since Specialization

Citations

This map shows the geographic impact of Ilia Fishbein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilia Fishbein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilia Fishbein more than expected).

Fields of papers citing papers by Ilia Fishbein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilia Fishbein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilia Fishbein. The network helps show where Ilia Fishbein may publish in the future.

Co-authorship network of co-authors of Ilia Fishbein

This figure shows the co-authorship network connecting the top 25 collaborators of Ilia Fishbein. A scholar is included among the top collaborators of Ilia Fishbein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilia Fishbein. Ilia Fishbein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis 2024 ·Pharmaceutics ·Ivan S. Alferiev, Kehan Zhang, (unknown), Richard F. Adamo, (unknown), Ilia Fishbein, (unknown), Robert J. Levy, Michael Chorny	1
2	Abstract 13842: A Macromolecule-Linked Prodrug of Rapamycin Shows Potent Growth Inhibitory Effects Against Activated Fibroblasts Mimicking Fibroproliferative Transformation in Pulmonary Hypertension 2023 ·Circulation ·Ivan S. Alferiev, George Bratinov, David B. Frank, Ilia Fishbein, Michael Chorny	0
3	Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models 2022 ·International Journal of Molecular Sciences ·Ivan S. Alferiev, (unknown), (unknown), Peng Guan, (unknown), Venkatadri Kolla, Ilia Fishbein, (unknown), Garrett M. Brodeur, Michael Chorny	6
4	Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1 2022 ·Scientific Reports ·(unknown), (unknown), Ivan S. Alferiev, Jonathan D. Smith, Philip W. Zoltick, Cory M. Tschabrunn, Robert L. Wilensky, Robert C. Gorman, Robert J. Levy, Ilia Fishbein	8
5	Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization 2020 ·Journal of Visualized Experiments ·(unknown), (unknown), Ivan S. Alferiev, Robert J. Levy, Stanley J. Stachelek, Ilia Fishbein	2
6	Stability and bioactivity of pepCD47 attachment on stainless steel surfaces 2020 ·Acta Biomaterialia ·(unknown), (unknown), Ivan S. Alferiev, Chandrasekaran Nagaswami, Lynn A. Spruce, Hossein Fazelinia, George Bratinov, Steven H. Seeholzer, Robert J. Levy, Ilia Fishbein, Stanley J. Stachelek	6
7	Enhanced biocompatibility of CD47-functionalized vascular stents 2016 ·Biomaterials ·(unknown), Ivan S. Alferiev, Chandrasekaran Nagaswami, John W. Weisel, Robert J. Levy, Ilia Fishbein, Stanley J. Stachelek	34
8	Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries 2015 ·Journal of Controlled Release ·Richard F. Adamo, Ilia Fishbein, Kehan Zhang, (unknown), Robert J. Levy, Ivan S. Alferiev, Michael Chorny	25
9	Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers 2014 ·Journal of Visualized Experiments ·Ilia Fishbein, (unknown), Richard F. Adamo, Michael Chorny, Robert J. Levy, Ivan S. Alferiev	7
10	Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: Implications for gene therapy of restenosis 2013 ·Atherosclerosis ·(unknown), Ivan S. Alferiev, Michael Chorny, Richard F. Adamo, Robert J. Levy, Ilia Fishbein	16
11	Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction 2013 ·Biomaterials ·Ilia Fishbein, (unknown), Michael Chorny, Jeanne M. Connolly, Richard F. Adamo, (unknown), Ivan S. Alferiev, Robert J. Levy	5
12	Magnetically Targeted Delivery of Therapeutic Agents to Injured Blood Vessels for Prevention of In-Stent Restenosis 2012 ·Methodist DeBakey Cardiovascular Journal ·Michael Chorny, Ilia Fishbein, Richard F. Adamo, (unknown), (unknown), Ivan S. Alferiev	8
13	Magnetic nanoparticles for targeted vascular delivery 2011 ·IUBMB Life ·Michael Chorny, Ilia Fishbein, (unknown), Ivan S. Alferiev	40
14	Adenoviral Gene Vector Tethering to Nanoparticle Surfaces Results in Receptor-Independent Cell Entry and Increased Transgene Expression 2006 ·Molecular Therapy ·Michael Chorny, Ilia Fishbein, Ivan S. Alferiev, Origène Nyanguile, Richard S. Gaster, Robert J. Levy	22
15	Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries 2004 ·Biomaterials ·Shmuel Banai, Michael Chorny, S. David Gertz, Ilia Fishbein, Jianchuan Gao, Louise Perez, (unknown), Aviv Gazit, Alexander Levitzki, Gershon Golomb	56
16	Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics 2002 ·Journal of Controlled Release ·Michael Chorny, Ilia Fishbein, Haim Danenberg, Gershon Golomb	288
17	Activated polyurethane modified with latent thiol groups 2002 ·Biomaterials ·Ivan S. Alferiev, Ilia Fishbein	23
18	Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-12951 2002 ·Transplantation ·Matthias Karck, Rolf Rüdiger Meliß, (unknown), Michael Mengel, Klaus Pethig, Alexander Levitzki, Shmuel Banai, Gershon Golomb, Ilia Fishbein, Michael Chorny, Axel Haverich	15
19	Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods 2002 ·Journal of Controlled Release ·Michael Chorny, Ilia Fishbein, Haim Danenberg, Gershon Golomb	45
20	Local delivery of mithramycin restores vascular reactivity and inhibits neointimal formation in injured arteries and vascular grafts 2001 ·Journal of Controlled Release ·Ilia Fishbein, Ron Brauner, Michael Chorny, Jianchuan Gao, Xing Chen, Hillel Laks, Gershon Golomb	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact